Four new grantees received the Catalyst Awards for Innovative Research Approaches for AMD.
CDA founded 30 years ago as one of the few private sources of funding aimed specifically at early-career vision researchers.
Study from RPB-supported researchers at Duke University suggests loss of blood vessels in retina reflect changes in brain health.
A study from an RPB-supported researcher at Northwestern University School of Medicine could speed up the diagnosis of retinal diseases.
Vision scientists who have received RPB funding will help lead all five research teams, which will seek to accelerate development of regenerative treatments for blindness.
(NAEVR) held its Fourth Annual Emerging Vision Scientists (EVS) Day on Capitol Hill and twenty early-stage investigators participated.
Research to Prevent Blindness (RPB) and Lions Clubs International Foundation (LCIF) announced today that they will continue their partnership in the RPB/LCIF Low Vision Research Award.
Four RPB-supported researchers and a Scientific Advisory Panel member have been honored with the prestigious 2018 António Champalimaud Vision Award for their groundbreaking research
RPB-funded researchers at Washington University School of Medicine in St. Louis (WUSTL) have found a correlation in 30 older patients between retina thinning and elevated levels of tau and amyloid proteins that are the hallmark of Alzheimer’s disease.
RPB and AUPO announce the 2018 recipient of the award focused on age-related macular degeneration.
The first patient receives an FDA-approved gene therapy for inherited retinal disease at Mass. Eye and Ear.
Award recipients to use IRIS Registry database to conduct population-based studies.
Many of the organization’s individual grants will now be open to researchers at any U.S. academic medical center.
RPB-supported researchers at the University of Southern California Roski Eye Institute conducted the human trial.
RPB celebrates five decades of sight-saving discoveries at NEI.
RPB hosted its fifth annual convening of organizations that fund vision research in Washington DC.
Partnership to utilize IRIS Registry database to advance patient care.
RPB-supported researchers made a critical discovery about the gene mutation that causes many retinal degenerative diseases, opening the door for a new line of research into potential treatments.
RPB-supported researchers make progress in characterizing the genetic components of Usher syndrome.
The model will allow researchers to better assess treatments for this hard-to-study cause of blindness.
The findings may have significant therapeutic implications for AMD, the most common cause of elderly blindness in the developed world
RPB-supported researchers at the University of Illinois at Chicago have identified an enzyme present in the cornea that triggers inflammation during and even after a herpes virus infection.
New RPB-supported research provides hope for transplants of neural stem cells as future treatment for brain injuries.